Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy
BMC Cancer, pp. 1-8, 2019.
Non-small-cell lung cancer Stage pIII-N2 Pneumonectomy Postoperative radiotherapy
There were few reports of postoperative radiotherapy (PORT) in stage pIII-N2 Non-small-cell Lung Cancer (NSCLC) patients receiving pneumonectomy followed by adjuvant chemotherapy. This study aims to evaluate safety and efficacy of PORT among these patients. Between Jan. 2004 and Dec. 2015, stage pIII-N2 NSCLC patients receiving pneumonect...More
Full Text (Upload PDF)
PPT (Upload PPT)